company background image
PIQ logo

Proteomics International Laboratories ASX:PIQ Stock Report

Last Price

AU$0.89

Market Cap

AU$115.8m

7D

1.7%

1Y

1.1%

Updated

23 Jun, 2024

Data

Company Financials +

Proteomics International Laboratories Ltd

ASX:PIQ Stock Report

Market Cap: AU$115.8m

PIQ Stock Overview

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics.

PIQ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Proteomics International Laboratories Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Proteomics International Laboratories
Historical stock prices
Current Share PriceAU$0.89
52 Week HighAU$1.40
52 Week LowAU$0.70
Beta0.59
11 Month Change-13.24%
3 Month Change-15.71%
1 Year Change1.14%
33 Year Change-4.32%
5 Year Change152.86%
Change since IPO293.33%

Recent News & Updates

Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Nov 16
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Recent updates

Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Nov 16
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

Sep 29
Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

May 10
We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Nov 17
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Aug 09
Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

Oct 20
We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

May 31
We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

Shareholder Returns

PIQAU Life SciencesAU Market
7D1.7%5.0%0.8%
1Y1.1%-10.6%10.3%

Return vs Industry: PIQ exceeded the Australian Life Sciences industry which returned -10.6% over the past year.

Return vs Market: PIQ underperformed the Australian Market which returned 10.3% over the past year.

Price Volatility

Is PIQ's price volatile compared to industry and market?
PIQ volatility
PIQ Average Weekly Movement7.9%
Life Sciences Industry Average Movement9.2%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: PIQ's share price has been volatile over the past 3 months.

Volatility Over Time: PIQ's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aRichard Lipscombewww.proteomics.com.au

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research.

Proteomics International Laboratories Ltd Fundamentals Summary

How do Proteomics International Laboratories's earnings and revenue compare to its market cap?
PIQ fundamental statistics
Market capAU$115.84m
Earnings (TTM)-AU$5.90m
Revenue (TTM)AU$3.03m

38.2x

P/S Ratio

-19.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PIQ income statement (TTM)
RevenueAU$3.03m
Cost of RevenueAU$2.11m
Gross ProfitAU$920.25k
Other ExpensesAU$6.82m
Earnings-AU$5.90m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.045
Gross Margin30.35%
Net Profit Margin-194.61%
Debt/Equity Ratio0%

How did PIQ perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.